Study of Dapagliflozin for heart function in acute heart failure
Treatments studied
Part of Heart & circulation clinical trials.
This trial tests if dapagliflozin, a medication usually used for diabetes, can help people with acute heart failure recover heart function. If you are in the hospital for heart failure, this study will check if the drug improves how your heart squeezes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You are hospitalized with acute heart failure and in stable condition
- Your kidney function is good enough (eGFR more than 25)
- You do not have type 1 diabetes or certain other medical conditions
- You have not taken an SGLT2 inhibitor (like dapagliflozin) before
- You do not have current atrial fibrillation or certain heart rhythm problems
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if dapagliflozin helps reduce fat around the heart in people with a type of heart failure where the heart pumps normally but is stiff. It might improve symptoms and overall health.
This study tests whether dapagliflozin can improve kidney and heart-related outcomes in people with severe chronic kidney disease (CKD). You would take the study medicine (or a comparison treatment) and be followed to see how your kidneys and heart do over time.
This study tests how a medication called DAPA (an SGLT2 inhibitor) affects the body in people with heart failure (with or without type 2 diabetes), or in some people with type 2 diabetes only. It may help researchers understand who could benefit most and what changes happen in the heart, using specialized heart imaging.
This trial tests whether adding dapagliflozin (a medication that helps protect the heart and kidneys) helps people with heart failure who are also on peritoneal dialysis. It may offer extra support for your heart and kidney health.
This trial tests whether giving gliflozin (a type of diabetes pill also used for heart failure) early in the emergency department helps older patients who are admitted for worsening heart failure. It aims to see if it can improve recovery and reduce the need for intensive treatment.
This trial tests whether a diabetes drug called dapagliflozin (also used for heart failure) can help people recover better after a recent heart attack. It's for adults who are already on standard blood thinners and have had a heart attack in the past week.
Hear when a new Congestive Heart Failure Acute trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.